GW Pharmaceuticals CEO: Defining CBD and THC-based Drugs | Mad Money | CNBC

GW Pharmaceuticals launched its first commercial drug in the U.S. last November. Jim Cramer talks with CEO Justin Gover to clear the air between CBD and marijuana-based medications.
» Subscribe to CNBC:
» Watch more Mad Money here:
» Read more about GW Pharmaceuticals here:
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Get More Mad Money!
Read the latest news:
Watch full episodes:
Follow Mad Money on Twitter:
Like Mad Money on Facebook:
Follow Cramer on Twitter:

Connect with CNBC News Online!
Find CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Google+:
Follow CNBC News on Instagram:

GW Pharmaceuticals CEO: Defining CBD and THC-based Drugs | Mad Money | CNBC

I accept that this data will be stored on the website after I clicked submit
I have read the privacy policy and accept it.

You’ve got an issue with young kids being put on 51-50 holds because they say suicidal comments. Thrown in the dark bowels of Hospitals. Not good for children’s psychology.

Americans talking about pot; let's watch the ignorance unfold.